financetom
Business
financetom
/
Business
/
--Gorman-Rupp Boosts Quarterly Dividend 2.8% to $0.185 per Share, Payable Dec. 10 to Holders of Record Nov. 15
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Gorman-Rupp Boosts Quarterly Dividend 2.8% to $0.185 per Share, Payable Dec. 10 to Holders of Record Nov. 15
Nov 3, 2024 11:29 AM

07:57 AM EDT, 10/25/2024 (MT Newswires) --

Price: 37.00, Change: -1.08, Percent Change: -2.84

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NuScale Power Raises $227.7 Million From Warrant Exercise
NuScale Power Raises $227.7 Million From Warrant Exercise
Dec 26, 2024
05:01 PM EST, 12/26/2024 (MT Newswires) -- NuScale Power ( SMR ) said late Thursday about 97% of its warrants were exercised by holders to buy its class A shares at $11.50 per share at redemption date, raising $227.7 million for the firm. The company said no warrants remained outstanding and they have ceased trading on the New York Stock...
Hongli Group Files Secondary Stock Shelf
Hongli Group Files Secondary Stock Shelf
Dec 26, 2024
05:04 PM EST, 12/26/2024 (MT Newswires) -- Hongli Group ( HLP ) late Thursday filed a preliminary prospectus for secondary sale by investors from time to time of 60 million ordinary shares they acquired from the Chinese steel producer in November. Hongli ( HLP ) on Nov. 13 issued 60 million shares priced at $0.55 apiece for $33 million. The...
Viracta Therapeutics Exploring Options, Including Potential Sale; Closes Phase 2 Trial of Nana-val
Viracta Therapeutics Exploring Options, Including Potential Sale; Closes Phase 2 Trial of Nana-val
Dec 26, 2024
05:02 PM EST, 12/26/2024 (MT Newswires) -- Viracta Therapeutics ( VIRX ) said late Thursday its board has launched a process to explore options, including a potential merger, sale or licensing deal. While the board reviews Viracta's options, the company said it has decided to close its phase 2 trial of Nana-val for the treatment of relapsed/refractory EBV+ lymphomas to...
Salesforce Insider Sold Shares Worth $2,133,803, According to a Recent SEC Filing
Salesforce Insider Sold Shares Worth $2,133,803, According to a Recent SEC Filing
Dec 26, 2024
05:01 PM EST, 12/26/2024 (MT Newswires) -- Amy E Weaver, President and CFO, on December 24, 2024, sold 6,221 shares in Salesforce ( CRM ) for $2,133,803. Following the Form 4 filing with the SEC, Weaver has control over a total of 53,861 shares of the company, with 53,861 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1108524/000112760224030073/xslF345X05/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved